Eye vein test could replace risky brain pressure monitoring

NCT ID NCT07222826

Recruiting now Diagnosis Sponsor: Compremium AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called CPMX3 that measures pressure in a small vein near the eye to estimate pressure inside the skull. Currently, measuring brain pressure requires surgery to place a probe inside the head, which carries risks like infection and bleeding. The trial will enroll 15 people who already have an invasive monitor in place, comparing the new device's readings to the standard method to see if it is safe and accurate.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CPMX3 device
What this could lead to: If successful, this could provide a safe, non-invasive way to measure pressure inside the skull, reducing the need for risky brain surgery.
What could go wrong: This is a very small, early safety and feasibility study with only 15 participants. The device may not prove accurate enough to replace current invasive methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracranial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL PRESSURE INTRACRANIAL PRESSURE CHANGES

Contacts and locations

Locations

Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.